Karyopharm Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Name: Karyopharm Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Karyopharm Therapeutics Inc
Rating: 1.27450
Author: Trendlyne DVM scores

about

Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company pioneering novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and oth...

4.77 0.22 (4.84%)

71.86% Fall from 52W High

337.5K

XNAS Volume

High volume today

XNAS 14 Jul, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

16.0 / 100

Technically Neutral

35.0 / 100

1Yr Price target upside is 506%

7 analysts

Karyopharm Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Karyopharm Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company pioneering novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and oth...

71.86% Fall from 52W High

High volume today

SWOT Analysis

Karyopharm Therapeutics Inc Live Price Chart